Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 45.00
+1.61 (3.71%)
At close: Mar 6, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 7.53 billion as of March 6, 2026. Its market cap has increased by 14.02% in one year.
Market Cap
7.53B
Enterprise Value
5.72B
Revenue
794.52M
Ranking
n/a
PE Ratio
43.73
Stock Price
45.00
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 7.53B, a decrease of -44.22%. That is a compound annual growth rate of -12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.53B | -16.67% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.11B |
| Chengdu Kanghua Biological Products | 8.05B |
| Youcare Pharmaceutical Group | 7.93B |
| Anhui Huaheng Biotechnology | 7.88B |
| Suzhou Fengbei Biotech Stock | 7.83B |
| Nanjing Vazyme Biotech | 7.82B |
| Zhejiang Ausun Pharmaceutical | 7.60B |